Nestle Likely In Lead To Buy Pfizer's $10B Baby Food Line
Swiss food giant Nestle SA is the favorite to buy Pfizer Inc.'s infant nutrition business, which could be worth $10 billion, an analyst said Thursday, partly because another leading bidder, France's...To view the full article, register now.
Already a subscriber? Click here to view full article